Comorbidity Assessment in Skin Cancer Patients: A Pilot Study Comparing Medical Interview with a Patient-Reported Questionnaire
Journal of Skin Cancer · 2015 · 2015 · 1-6
DOI: 10.1155/2015/953479 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Skin Cancer, 2015. Verfasst von Erica H Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NCI NIH HHS.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Comorbidities are conditions that occur simultaneously but independently of another disorder. Among skin cancer patients, comorbidities are common and may influence management.
Objective
We compared comorbidity assessment by traditional medical interview (MI) and by standardized patient-reported questionnaire based on the Adult Comorbidity Evaluation-27 (ACE-27).
Methods
Between September 2011 and October 2013, skin cancer patients underwent prospective comorbidity assessment by a Mohs surgeon (MI) and a radiation oncologist (using a standardized patient-reported questionnaire based on the ACE-27, the PRACE-27). Comorbidities were identified and graded according to the ACE-27 and compared for agreement.
Results
Forty-four patients were evaluated. MI and PRACE-27 identified comorbidities in 79.5% and 88.6% ( p = 0.12 ) of patients, respectively. Among 27 comorbid ailments, the MI identified 9.9% as being present, while the PRACE-27 identified 12.5%. When there were discordant observations, PRACE-27 was more likely than MI to identify the comorbidity ( O R = 5.4 , 95% CI = 2.4–14.4, p < 0.001 ). Overall comorbidity scores were moderate or severe in 43.2% (MI) versus 59.1% (PRACE-27) ( p = 0.016 ).
Limitations
Small sample size from a single institution.
Conclusion
Comorbidities are common in skin cancer patients, and a standardized questionnaire may better identify and grade them. More accurate comorbidity assessments may help guide skin cancer management.
Autor:innen und Institutionen
- Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA.
- Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA ; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Lee, E. H., Nijhawan, R. I., Nehal, K. S., Dusza, S. W., Levine, A., Hill, A., & Barker, C. A. (2015). Comorbidity Assessment in Skin Cancer Patients: A Pilot Study Comparing Medical Interview with a Patient-Reported Questionnaire. Journal of Skin Cancer, 2015, 1-6. https://doi.org/10.1155/2015/953479
Vancouver
Lee EH, Nijhawan RI, Nehal KS, Dusza SW, Levine A, Hill A, et al. Comorbidity Assessment in Skin Cancer Patients: A Pilot Study Comparing Medical Interview with a Patient-Reported Questionnaire. Journal of Skin Cancer. 2015;2015:1-6. doi:10.1155/2015/953479
BibTeX
@article{Lee2015,
author = {Lee, Erica H and Nijhawan, Rajiv I and Nehal, Kishwer S and Dusza, Stephen W and Levine, Amanda and Hill, Amanda and Barker, Christopher A},
title = {Comorbidity Assessment in Skin Cancer Patients: A Pilot Study Comparing Medical Interview with a Patient-Reported Questionnaire},
journal = {Journal of Skin Cancer},
year = {2015},
volume = {2015},
pages = {1--6},
doi = {10.1155/2015/953479}
}
EUVIMED